End-Payors Again Denied Cert. In Niaspan Pay-For-Delay MDL

By Dave Simpson · August 17, 2021, 9:48 PM EDT

A Pennsylvania federal judge once again declined to certify a class of end-payors in their suit alleging improper pay-for-delay settlements between AbbVie and Teva Pharmaceuticals Industries aimed at barring generic forms...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

IN RE: NIASPAN ANTITRUST LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

September 17, 2013

Recent Articles By Dave

January 30, 2023
Feds Call Convicted Theranos COO Balwani A 'Flight Risk'
December 14, 2022
Health Net Hit With $14.4M Verdict Over Surgery Delay
December 13, 2022
DeSantis Petitions Fla. Justices For COVID-19 Vax Grand Jury
December 12, 2022
Juul To Pay Pa. $38.8M To Settle Youth Marketing Claims
December 05, 2022
Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
December 02, 2022
Doctor Repped By RFK Jr. Targets COVID Misinformation Law
November 18, 2022
DOJ Will Ask DC Circ. To Block UnitedHealth-Change Deal
November 17, 2022
Akin Gump Gets Green Light To Represent Endo Claimants
November 04, 2022
SF-Walgreens Opioid Trial Called Off Amid Settlement Talks
October 31, 2022
Direct HIV Med Buyers Seek OK Of $10.8M Bristol-Myers Deal